Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme
11 October 2021
The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.
£3M invested to drive forward early translation through five new Oxford-Bristol Myers Squibb Fellowships
9 December 2020
Five new Oxford-Bristol Myers Squibb Fellowships representing an investment of £3M have been announced today*. The fellowships (formerly Oxford-Celgene) will support postdoctoral researchers and clinicians across five departments within the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development.
'Family trees' of Acute Myeloid Leukaemia treated with enasidenib mapped for the first time
17 July 2018
The study led by MRC WIMM researchers as part of an international team aims to understand what happens when patients stop responding to treatment.